Responses
Clinical/translational cancer immunotherapy
Original research
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
